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Abstract
Curcumin preparations typically contain a mixture of polyphenols, collectively referred to as curcuminoids. In addition to
the primary component curcumin, they also contain smaller amounts of the co-extracted derivatives demethoxycurcumin
and bisdemethoxycurcumin. Curcuminoids can be differentially solubilized in serum, which allows for the systematic
analysis of concentration-dependent cellular binding, biological effects, and metabolism. Technical grade curcumin was
solubilized in fetal calf serum by two alternative methods yielding saturated preparations containing either predominantly
curcumin (60%) or bisdemethoxycurcumin (55%). Continual exposure of NT2/D1 cells for 4–6 days to either preparation in
cell culture media reduced cell division (1–5 mM), induced senescence (6–7 mM) or comprehensive cell death (8–10 mM) in
a concentration-dependent manner. Some of these effects could also be elicited in cells transiently exposed to higher
concentrations of curcuminoids (47 mM) for 0.5–4 h. Curcuminoids induced apoptosis by generalized activation of caspases
but without nucleosomal fragmentation. The equilibrium binding of serum-solubilized curcuminoids to NT2/D1 cells
incubated with increasing amounts of curcuminoid-saturated serum occurred with apparent overall dissociation constants
in the 6–10 mM range. However, the presence of excess free serum decreased cellular binding in a hyperbolic manner.
Cellular binding was overwhelmingly associated with membrane fractions and bound curcuminoids were metabolized in
NT2/D1 cells via a previously unidentified reduction pathway. Both the binding affinities for curcuminoids and their
reductive metabolic pathways varied in other cell lines. These results suggest that curcuminoids interact with cellular
binding sites, thereby activating signal transduction pathways that initiate a variety of biological responses. The dose-
dependent effects of these responses further imply that distinct cellular pathways are sequentially activated and that this
activation is dependent on the affinity of curcuminoids for the respective binding sites. Defined serum-solubilized
curcuminoids used in cell culture media are thus suitable for further investigating the differential activation of signal
transduction pathways.
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Introduction
Curcumin has been implicated as beneficial in numerous
medicinal applications. These include inhibition of tumor prop-
agation, protection against Alzheimer disease and antiinflamma-
tory properties. In vitro, curcumin slows the rate of cell division or
induces apoptosis in a concentration-dependent manner (for
reviews see: [1,2,3,4,5]).
Curcuminoids are polyphenols extracted from the root of
Curcuma longa [6,7]. They impart the yellow color to the spice
turmeric, where they occur in amounts of 2–8% [8,9,10].
Curcumin is the main curcuminoid ingredient in turmeric (65–
80%), in addition to smaller amounts of two structurally related
derivatives that lack either one (demethoxycurcumin, 15–25%) or
both (bisdemethoxycurcumin, 5–15%) methoxy groups in the
phenyl rings [11,12]. Collectively, these compounds are referred to
as curcuminoids, and they are typically co-extracted from turmeric
in commercial preparations of curcumin. All curcuminoids have
been implicated in biological activity, although the extent of their
relative contributions may differ [2].
Curcuminoids are highly insoluble in aqueous solutions.
Therefore, in cell culture studies, small amounts of a concentrated
stock solution of curcuminoids predissolved in an organic solvent
are typically added to the cell culture medium to achieve desired
final concentrations. However, upon adding such predissolved
curcuminoids to aqueous solutions, they initially precipitate.
Although some or most of the precipitated material may gradually
dissolve, the final concentrations and compositions of the actual
soluble curcuminoids remain inferential, since they are based on
the dilution of the total amount added. Methods have been
described that differentially solubilize high concentrations of
biologically active curcuminoids directly in serum. This provides
an opportunity to prepare tissue culture media containing defined
concentrations of serum-solubilized curcuminoids with varying
compositions [13].
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39568The effect of such curcuminoid preparations on NT2/D1
embryonal carcinoma cells was here systematically investigated in
terms of binding, metabolism, and biological effects. These cells
divide rapidly with limited contact inhibition and they are also
capable of differentiating into a variety of neuronal and non-
neuronal cell types, depending on culture conditions and upon
exposure to specific inducers such as retinoic acid and hexam-
ethylene bisacetamide [14]. This cell line has also been used to
investigate the effect of other anticancer drugs [15,16] and
mechanisms of developmental processes [17]. Some results were
compared to those obtained with HeLa and CCF-STTG1 cells.
Results
Curcuminoids Solubilized in Fetal Calf Serum
Differentially Bind to NT2/D1 Cells
The curcumin preparation used in this study (technical grade,
Cayman Chemical Company) contained a mixture of curcumin
(CUR, 69%), demethoxycurcumin (DMC, 19%), and bisde-
methoxycurcumin (BDMC, 12%). These curcuminoids were
solubilized in fetal calf serum (FCS) either by mixing them directly
with the solid powder (SOLID-solubilized) or by adding small
aliquots of curcuminoids dissolved in dimethylsulfoxide (DMSO-
solubilized). This procedure yielded curcuminoid-saturated pre-
parations, that could be further diluted with cell culture media
without precipitations or changes in composition [13]. Both
preparations were directly diluted with cell culture medium
(DMEM, Dulbecco’s Minimal Essential Medium) for a final
concentration of 5% FCS. Although the total amount of
solubilized curcuminoids was similar (46–49 mM), their composi-
tion differed between the two methods of preparation. In medium
containing serum with SOLID-solubilized curcuminoids, BDMC
(55%) was preferentially solubilized with smaller amounts of DMC
(24%) and CUR (21%). By comparison, media containing serum
with DMSO-solubilized curcuminoids were composed primarily of
CUR (60%) with smaller amounts of DMC (23%) and BDMC
(17%), which is similar to the curcuminoid content of the original
powdered preparation. A mixture (1:1) of the two preparations
(SOLID+DMSO) produced a more balanced curcuminoid com-
position (CUR: 40%, DMC: 24%, and BDMC: 36%) (Fig. 1A).
NT2/D1 cells were incubated for 1 h with media containing
these three curcuminoid preparations (SOLID, DMSO, SO-
LID+DMSO) in a total FCS concentration of 5%. The amount of
curcuminoids bound to cells and their concentrations in the media
were then determined. In all cases, the total curcuminoid
concentrations in the media had declined to levels of 70–75% of
the original value while the overall composition of curcuminoids
remained largely unchanged (Fig. 1B). A significant amount of
curcuminoids remained bound to the NT2/D1 cells. However, the
cellular-bound curcuminoids showed different compositions than
those found in the media. In general, the relative amount of
cellular-bound CUR had increased at the expense of BDMC while
the variation in the relative amount of DMC was less consistent
(Fig. 1C). These observations served as the basis for further
experiments in this study.
Curcuminoids Reduce NT2/D1 Proliferation Rates or
Induce Cell Death in a Dose-dependent Manner
The variation in relative solubility of SOLID- and DMSO-
solubilized curcuminoids in FCS and their concomitant binding to
NT2/D1 cells allows for a comparison of their possible differential
biological effects. To assess the influence of curcuminoids on cell
proliferation and survival, media containing saturated concentra-
tions of SOLID-(46 mM) and DMSO-solubilized (49 mM) were
diluted with standard medium (DMEM, 5% FCS without
curcuminoids) to attain 1–10 mM curcuminoid concentrations.
NT2/D1 cells at 20–30% confluence were then incubated for 4–6
days and the media were replenished every 24 h. A dose-
dependent reduction in the rate of cell division was observed at
1–5 mM curcuminoid concentrations. The cellular doubling time
gradually increased from about 19 h in cultures grown without
curcuminoids, to 44 h in media containing 5 mM initial curcumi-
noid concentrations. There was no evidence of significant cell
death at these curcuminoid concentrations and the rate of cell
growth was similar in cells exposed to preparations containing
either SOLID- or DMSO-solubilized curcuminoids (Fig. 2A). At
6–7 mM curcuminoid concentrations, partial cell death was
apparent within the first two days of incubation. However, the
cell number thereafter stabilized at a level of 40–60% of
the starting density. Further cell division was suppressed and the
surviving cells remained viable while undergoing changes in
morphology (see below). At higher 8–10 mM curcuminoid
concentrations, dose-dependent cell death was evident with no
surviving cells after four days of incubation. No significant
differences were noted in the cellular responses between SOLID-
and DMSO-solubilized curcuminoid preparations (Fig. 2B, C). By
comparison, HeLa and CCF-STTG1 cells were considerably less
sensitive to the effects of curcuminoids and required up to 3-fold
higher minimal concentrations to induce comprehensive cell death
(Table 1).
Cellular Senescence of NT2/D1 Cells in Response to
Curcuminoids
The cellular response of NT2/D1 cells at intermediate 6–7 mM
curcuminoid concentrations was further examined by phase
contrast microscopy. NT2/D1 cells grown in standard medium
were ordinarily relatively small and tended to propagate in
coalescing groups (Fig 3A). However, soon after incubation with
6–7 mM curcuminoids, cell division stopped and limited cell death
was apparent. After the first 4 days of incubation, the remaining
individual cells had grown larger and distributed themselves over
the available growth surface (Fig. 3B). After 12 days, individual
cells had further expanded in size, concurrent with a gradual but
limited decrease in cell number. Profound changes in cellular
morphology were apparent with increased cytoplasmic, nuclear,
and nucleolar size. The cytoplasm was often vacuolated with
numerous irregular processes and polynucleated cells were
frequently observed (Fig 3C). These changes were irreversible in
that they persisted for weeks even after curcuminoid-containing
media had been replaced with standard media. These terminal
morphological changes were reminiscent of cells undergoing
senescence [18,19]. To further evaluate this possibility, dividing
cells in standard media and cells exposed to 6–7 mM curcuminoids
were stained for the presence of SA-b-galactosidase [20]. The
detection of this compound at suboptimal pH conditions (pH 6)
reflects an increase in lysosomal mass in aging cells and it is widely
regarded as a marker for senescence [21]. NT2/D1 cells grown
without curcuminoids showed no SA-b-galactosidase staining
(Fig. 3D), whereas cells incubated with 6–7 mM curcuminoids
showed increasingly vigorous staining after 4 and 12 days (Fig. 3E,
F). Altogether, the irreversible withdrawal from the cell cycle, the
morphological changes of the cells, and the detection of SA-b-
galactosidase at pH 6 suggested that exposure to curcuminoids at
6–7 mM concentrations induced terminal cessation of cell division
and cellular senescence. Although the images in Fig. 3 illustrate the
effects of SOLID-solubilized curcuminoids, the results were
indistinguishable with DMSO-solubilized curcuminoids.
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observed with CCF-STTG1 cells, albeit at the higher 20–22 mM
concentration of SOLID-solubilized curcuminoids (not shown). In
contrast, HeLa cells displayed a less pronounced senescent
phenotype that occurred within a narrow 18–19 mM curcuminoid
concentration range (Table 1). It is thus conceivable that
curcuminoids may not induce senescence in all cell lines, or that
the required concentration range to achieve this response is
exceedingly narrow.
Curcuminoids Induce Cell Death by Apoptosis
Since curcuminoid concentrations above 8–10 mM resulted in
complete cell death within four days of incubation, the mechanism
by which this occurred was further examined. For this purpose,
NT2/D1 cells were incubated for shorter periods with maximal
46–49 mM curcuminoid concentrations. At these high concentra-
tions, pervasive cell death was observed within 24 h of incubation,
which facilitated the assays for apoptotic mechanisms. The
structural changes in the cells included membrane blebbing,
dissolution of the nuclear membrane, and cell fragmentation,
which are all manifestations of apoptosis (Fig. 4A, B). Indeed, these
structural responses coincided with a generalized activation of
caspases. Maximum activation was uniformly observed after 12–
18 hours of incubation (Fig. 4 C). The most prominent activation
occurred with caspases 3/7. The additional activation of caspase 8
and to a lesser extent caspase 9, indicated a mixture of concurrent
or sequential extrinsic and intrinsic pathways. However, the
activation of other caspases suggested a more universal activation
mechanism at these curcuminoid concentrations. Conversely,
apoptosis-associated chromosomal DNA fragmentation could not
be demonstrated with either curcuminoid preparation, whereas
DNA fragmentation was observed in comparable apoptotic
cultures incubated with 5 mM camptothecin for 6 h (Fig. 4D).
Overall, these results show that at low curcuminoid concentra-
tions (,5 mM) the rate of cell division diminished and at higher
concentrations (.8 mM) cell death by apoptosis was induced in
a dose dependent manner. However, even at curcuminoid
concentrations as high as 46–49 mM, it took about 12–18 h
before morphological changes became apparent and 6 h before
caspase activation was observed. At intermediate (6–7 mM)
curcuminoid concentrations, cell division initially ceased and
cellular morphology began to change. This early step could
represent a form of cellular differentiation, although a specific cell
type has not yet been determined. Upon longer exposure, cells
irreversibly withdraw from the cell cycle and adopt a morphology
consistent with senescence. In all instances, similar results were
observed with curcuminoid preparations containing predominant-
ly CUR (DMSO-solubilized) or BDMC (SOLID-solubilized).
Curcuminoids Incubated with NT2/D1 Cells are Rapidly
Depleted from the Medium
The dose-response effects observed with NT2/D1 cells were
obtained with initial curcuminoid concentrations in media that
were replenished every 24 h. The fate of the curcuminoids in cells
and media during the period between media replacements was
further examined, as it would depend on factors such as cellular
binding, metabolism, and chemical decomposition. For this
Figure 1. Distribution of curcuminoids in NT2/D1 cells and culture medium. Left panel: SOLID-solubilized curcuminoids in FCS (SOLID).
Center panel: DMSO-solubilized curcuminoids in FCS (DMSO). Right panel: A 1:1 mixture of SOLID- and DMSO-solubilized curcuminoids
(SOLID+DMSO). Square brackets show total curcuminoid concentrations in media. The relative molar amounts (%) of BDMC (B), DMC (D), and CUR (C)
are indicated in each panel. (A) Starting composition of curcuminoids in media before incubation with cells. (B). Curcuminoid composition in media
after 1 h incubation with cells. (C) Curcuminoids extracted from cells after 1 h incubation with media depicted in A.
doi:10.1371/journal.pone.0039568.g001
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starting concentration of curcuminoids (DMSO+SOLID) for 5 h.
Within 5 h of incubation, the curcuminoid concentration in the
media had decreased to about 59% of the original value. About
half of that decrease occurred during the first 0.5 h of incubation,
which was followed by a more gradual decline for the remaining
period. The initial media depletion of curcuminoids coincided
with the establishment of maximum cellular binding, which was
attained after about 0.5 h. Thereafter, the levels of cellular-bound
curcuminoids effectively remained unchanged for the remaining
5 h incubation period (Fig. 5A). These cellular binding data are
similar to those observed in other studies [22,23].
Upon longer incubation, media curcuminoid concentrations
continued to diminish from about 50% of the original value after
6 h to 12% after 24 h (Fig. 5B). In media incubated under the
same conditions without cells, curcuminoid concentrations also
decreased, albeit at a slower and essentially linear rate. Although
initially stable, cellular binding of curcuminoids significantly
decreased between 6 and 24 h of incubation (Fig. 5B).
Comparing chromatograms of curcuminoids extracted from
media incubated with or without cells allowed for a more
differentiated evaluation of the results. In media incubated without
cells, the concentration of CUR had decreased to about 17% of
the starting concentration within 24 h, whereas BDMC and, to
a lesser extent, DMC were more stable. In contrast, in media
incubated with cells, all three curcuminoids had decreased to
values of less than 16% (Fig. 5C). By comparison, the binding of
CUR to cells had only declined to 48% of the original value (1 h),
whereas the binding of BDMC and DMC had decreased to 35%
and 25%, respectively (Fig. 5D).
These results show that both media concentrations and
cellular binding of curcuminoids significantly decreased during
the 24 h incubation period. Some of this concentration decline
in the media can be accounted for by chemical decomposition
[13,24], which is evident in media incubated without cells.
Indeed, under these conditions most of the decrease in
curcuminoid concentration can be attributed to the chemical
instability of CUR. In contrast, BDMC and to a lesser extent
DMC are remarkably stable. In the presence of cells, initial
cellular binding within the first 0.5 h of incubation also
contributes to the decline in media curcuminoid concentration.
Indeed, the robust binding of CUR to cells after 24 h of
incubation, despite low levels in the media, suggests that this
binding occurred at an earlier stage and that CUR bound to
cells is more chemically stable. Overall, the data suggest that
the decline in CUR concentration in the media is primarily due
to chemical decomposition and, to a lesser extent, early cellular
binding and metabolism. In contrast, the removal of BDMC
and DMC from the media and the subsequent lower levels of
cellular binding implies robust cellular metabolism of these
compounds, which would be considerably slower for CUR.
Cellular-bound Curcuminoids are Primarily Associated
with Membrane Fractions
To elucidate the subcellular target for cellular binding, NT2/
D1 cells were incubated with curcuminoids at a concentration of
47 mM (SOLID+DMSO) for 1 h, at which time maximum cellular
binding had been firmly established. To produce different degrees
of cellular fragmentation, cellular disruption was achieved either
by gentle homogenization in hypotonic buffer, three cycles of
freeze-thawing combined with intermittent vortexing with glass
beads, or by sonication. The cell-free preparations were then
subjected to three successive centrifugations (Fig. 6A). The first
low-speed centrifugation (1,0006g) separated unbroken cells, large
membrane fractions (cellular ghosts) and nuclei (pellet P1). The
supernatant (S1) of that step was centrifuged at higher speed
(15,0006g) to separate intermediate sized membrane fractions and
organelles (pellet P2). The supernatant (S2) of that step was further
centrifuged at 100,0006g to pellet residual membrane vesicles not
Figure 2. Concentration-dependent effects of curcuminoids on
NT2/D1 cell division and survival. (A) The effect of 0–5 mM
curcuminoid starting concentrations in incubation media on cellular
doubling time. Curcuminoids were either SOLID-(%) or DMSO-
solubilized (&). (B) The effect on cell survival of 6–10 mM starting
concentrations of SOLID-solubilized curcuminoids. (C) The effect on cell
survival of 6–10 mM DMSO-solubilized curcuminoids.
doi:10.1371/journal.pone.0039568.g002
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consisted largely of cytoplasmic material.
When cells were gently homogenized in hypotonic medium
(Fig. 6B, C, I), microscopic examination revealed predominantly
large membrane fractions (cellular ghosts) with free or trapped
Table 1. Selected curcuminoid effects and binding parameters in different cell lines.
NT2/D1 HELA CCF-STTG1
Doubling time (S.D.)
1 18.94 (0.74) h 27.81 (3.57) h 35.53 (2.85) h
KD-SOLID (S.E.) 6.3 (1.0) mM 17.0 (2.9) mM 25.6 (5.2) mM
BMAX-SOLID (S.E.)
2 19.0 (0.8) nmol 12.5 (1.3) nmol 15.7 (1.5) nmol
KD-DMSO (S.E) 7.2 (1.5) mM 22.2 (3.5) mM 29.9 (7.5) mM
BMAX-DMSO (S.E.)
2 22.0 (1.2) nmol 15.8 (1.2) nmol 20.4 (2.7) nmol
Cell Death [Curcuminoids]
3 $8 mM $20 mM $24 mM
Senescence [Curcuminoids]
3 6–7 mM 18–19 mM 20–22 mM
Primary Metabolites (after 24 h incubation) C*, D*, B*
4 Hexahydro-curcuminoids Hexahydro-Octahydro-curcuminoids
1Doubling time with standard deviation (S.D.) of cells grown in DMEM with 5% fetal calf serum.
2Maximum specific cellular binding of curcuminoids (BMAX) determined from the respective binding curves and presented as the amount bound to cells (nmol) per mg
of total cellular protein with standard error (S.E.).
3Determined with SOLID-solubilized curcuminoids. The values indicate the required minimal initial concentrations of curcuminoids in the media to achieve 100% cell
death within 4 d of incubation with media changes every 24 h. Cellular senescence was assessed after 6 days of incubation.
41,7-bis(4-hydroxy-3-methoxyphenyl)-5-hydroxy-1-heptene-3-one [CUR metabolite, C*]. 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-5-hydroxy-1-heptene-3-
one [DMC metabolite, D*]. 1,7-bis (4-hydroxyphenyl)-5-hydroxy-1-heptene-3-one [BDMC metabolite, B*].
doi:10.1371/journal.pone.0039568.t001
Figure 3. Cellular senescence in response to curcuminoids. Phase contrast micrographs of NT2/D1 cells incubated in media without
curcuminoids (A and D) or with 6 mM SOLID-solubilized curcuminoids in FCS for 4 (B and E) and 12 (C and F) days. Panels D, E, and F show cells
stained for SA-b-galactosidase activity at pH 6 (blue color).
doi:10.1371/journal.pone.0039568.g003
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curcuminoids, most of the binding activity occurred in pellet P1,
indicating that curcuminoids were bound to unbroken cells or
large membrane fractions. Some curcuminoid binding was also
present in pellet P2, and very little binding in pellet P3 and
cytoplasmic supernatant S3 (Fig. 6B). When the curcuminoid
binding activity was normalized to protein content in the various
fractions, the highest binding activity was observed in pellet P2
(Fig. 6C). In both instances, the cytoplasmic supernatant had
exceedingly low curcuminoid content (Fig. 6B, C).
Cells that were disrupted by freeze-thawing (Fig. 6B, C, II),
produced largely intermediate sized membrane fragments together
with free nuclei and smaller fragments appearing as cell debris. As
a result, curcuminoid binding shifted away from pellet P1 to the
higher speed pellets P2 and P3 (Fig. 6B, C). This trend also
extended to fractions normalized to protein content (Fig. 6C).
After sonication (Fig. 6, III), cell disruption was exhaustive with
few intermediate sized membrane fractions and larger amounts of
cell debris. Although many of the nuclei had also been disrupted,
no free nucleic acids were evident in the buffer. Under these
harsher conditions of cell disruption, curcuminoid binding was
transferred further toward the high speed pellet P3 at the expense
of pellets P1 and P2. Again, little or no curcuminoid was detected
in cytoplasmic fraction S3 (Fig. 6B, C).
Differential centrifugation by itself is inherently unreliable in the
purification of subcellular particles. This is due to excessive cross-
contamination with membrane particles of variable sizes with
specific organelles of interest. For an exhaustive characterization,
further purification by equilibrium centrifugation in sucrose
gradients would be essential. However, such centrifugations are
usually quite long (.16 h) and in the case of curcuminoid binding,
the stability of the binding complex would be a serious concern.
Nonetheless, for a preliminary assignment of the curcuminoid
binding activity, differential centrifugation was here applied to
cells that had been subjected to increasingly harsher disruption
procedures. The results clearly demonstrate that the overwhelming
curcuminoid binding activity is located to membrane fractions.
The precise membrane components associated with this binding
remain to be determined. However, further results discussed below
suggest that the cell membrane is the primary binding target.
Figure 4. Induction of apoptosis by curcuminoids. (A) Phase contrast micrograph of NT2/D1 cells incubated with 47 mM media concentration
of DMSO- solubilized curcuminoids for 18 h. Extensive cell death is indicated by rounding and detachment of cells. (B) At higher magnification,
morphological changes consistent with apoptosis are observed. (C) Caspase activation by curcuminoids (46–49 mM) incubated for 0 (black bars), 6,
12, or 18 h either with SOLID- (gray bars) or DMSO-solubilized (white bars) curcuminoids. The activities reported for caspase 3 are to be considered
a combination of the activities for caspases 3 and 7, since these share the same substrate and inhibitor specificity. (D) Detection of oligosomal DNA
fragmentation by electrophoresis in 1% agarose and ethidium bromide staining. Lane 1: NT2/D1 cells after 6 h of incubation with 5 mM
camptothecin, lane 2: Cells incubated without additives, lanes 3–5 cells incubated with 49 mM curcuminoids (DMSO-solubilized) for 6 h (lane 3), 12 h
(lane 4), and 18 h (lane 5).
doi:10.1371/journal.pone.0039568.g004
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the nuclear pellet (1,0006g) even after sonication, it is unlikely that
nuclear binding is a substantial contributor. In particular, since
Figure 5. Curcuminoids bound to NT2/D1 cells and their
concentration in media as a function of incubation time. (A)
Cells were incubated with media containing 27 mM starting concentra-
tions (0 min) of curcuminoids (SOLID+DMSO). The amount of curcumi-
noids bound to cells (&, right axis) and their concentration in media (N,
left axis) during 5 h of incubation. (B) Cells incubated for 24 h with
media containing a 27 mM starting concentration (100%) of curcumi-
noids (SOLID+DMSO). Left panel: The relative concentrations (%) of
curcuminoids in the media after 0, 6, 12, 18, and 24 h of incubation
either in the presence (black bars) or absence (white bars) of cells. Right
panel: The amounts of curcuminoids bound to cells after 1, 6, 12, 18,
and 24 h of incubation relative to the amount of curcuminoids bound
to cells after 1 h of incubation (100%). (C) Representative chromato-
grams showing the elution profiles of curcuminoids in media before
incubation (0 h, left panel) and after 24 h of incubation without cells
(center panel) or with cells (right panel). The integrated and adjusted (e)
values under each individual peak are expressed relative to the
respective starting concentrations (100%). (D) Curcuminoid binding to
cells after 1 h (left panel) and 24 h (right panel). Curcuminoids bound
after 24 h of incubation are expressed relative to the amount bound
after 1 h (100%).
doi:10.1371/journal.pone.0039568.g005
Figure 6. Subcellular fractionation of curcuminoids bound to
NT2/D1 cells. (A) Schematic outline of fractionation procedure. (B)
Relative distribution of total curcuminoids in centrifugal pellets 1–3
(P1–P3) and final supernatant (S3) as outlined in A. Cells were disrupted
by either by homogenization (I), freeze-thawing (II) or sonication (III) in
hypotonic medium. The amounts of curcuminoids in the respective
fractions are expressed relative to the amount of curcuminoids bound
to whole cells (100%). (C) Same as in B except that curcuminoids were
normalized to the amount of protein in the respective fractions.
doi:10.1371/journal.pone.0039568.g006
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PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e39568nuclei purified by detergent methods show little or no binding
activity when incubated directly with curcuminoids (not shown).
The Dose-dependent Binding of Curcuminoids to NT2/
D1 Cells is Saturable and Competed by Free Serum
The overall equilibrium dissociation constants (KD) sites
curcuminoids bound to NT2/D1 cells was determined by
incubating increasing amounts of saturated serum-solubilized
curcuminoids with NT2/D1 cells for 1 h. The amount of
cellular-bound and the concentration of unbound curcuminoids
were determined and the resulting data were fitted to binding
curves (Fig. 7A). The simplified premise here is that soluble
curcuminoids (CSOL) in the media bind to cellular sites that will
here for operational purposes be referred to as receptors (R). Such
soluble curcuminoids would then form the complex C-R with the
cellular binding sites as described by the equilibrium:
CSOLzR<C{R
Since the total number of receptors available for specific binding
(RT) is proportional to the number of cells and the number of
unbound receptors [R]=[RT]-[C-R], the dissociation constant is
described by the equation:
KD~
(½RT {½C-R )½CSOL 
½C-R 
Rearranged and with the factor m[CSOL] added to account for
non-specific binding:
½CR ~
½RT ½CSOL 
KDz½CSOL 
zm½CSOL 
The thus obtained apparent overall KDs for total curcuminoid
binding to NT2/D1 cells were similar for SOLID-solubilized
(KD=6.27 mM) and DMSO-solubilized (KD=7.23 mM) curcu-
minoids. However, when the SOLID- and DMSO-solubilized
curcuminoids were mixed, the apparent KD increased to
10.24 mM. The degree of non-specific binding, which was
reflected by the slope (m) of the linear segment of the curve
(m[CSOL]), depended on the method of curcuminoid-solubilization
and increased in the sequence SOLID,DMSO,SOLID+DMSO
(Fig. 7A).
Curcuminoid-binding to HeLa and astrocytoma CCF-STTG1
cells occurred with a 3- to 4-fold lower affinity than to NT2/D1
cells. The KD-values ranged from 17 mM (HeLa) and 25.6 mM
(CCF-STTG1) for SOLID-solubilized to 22.2 mM (HeLa) and
29.9 mM (CCF-STTG1) for DMSO-solubilized curcuminoids. In
contrast, the maximum specific binding of curcuminoids to each
cell line (BMAX) was less variable (Table 1).
When binding of individual curcuminoids to NT2/D1 cells was
plotted against total free curcuminoids, the apparent KD values for
individual curcuminoids increased in the order BDMC (2.81–
5.49 mM),DMC (6.16–8.70 mM),CUR (8.68–12.05 mM). Fur-
thermore non-specific binding was considerably more pronounced
with CUR than with BDMC or DMC. This resulted in an increase
in relative binding of CUR over BDMC and DMC, which was
particularly apparent at higher soluble curcuminoid concentra-
tions (compare Fig. 1). It should also be noted that pure synthetic
curcumin and analytical grade curcumin (.90% CUR) resulted in
higher apparent KD values of 19.05 and 18.13 mM, respectively
(not shown).
Figure 7. The dose-dependent binding of curcuminoids to NT2/
D1 cells. (A) Binding dose curves with variable serum and curcuminoid
concentrations in media containing FCS with saturated SOLID(S)-[N,
short dash] and DMSO(D)-solubilized [&, long dash] curcuminoids, and
a 1:1 mixture of the two (S+D) [., solid line]. The data points represent
values from three independent experiments normalized to cell number.
The following additional statistical parameters were calculated: R
2-
values: 0.99 (S), 0.98 (D), and 0.99 (S+D); KDs: 6.2761.03 mM (S),
7.2361.54 mM (D), 10.2461.36 mM( S +D); and the slope m (see equation
in text) indicating degree of non-specific binding: 1.9610
23 (S),
2.9610
23 (D), and 3.9610
23 (S+D). (B) Binding dose curves with
variable curcuminoid concentrations (S+D) at three constant total
serum concentrations (5%, 50%, and 100%). (C) Binding dose curve with
constant 47 mM curcuminoid concentration (S+D) and variable serum
concentration.
doi:10.1371/journal.pone.0039568.g007
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in 10% albumin were as follows: SOLID: 7.29 mM, DMSO:
8.35 mM, and SOLID+DMSO: 19.85 mM. Non-specific binding
to cells incubated with albumin-solubilized curcuminoids was
considerably lower or non-existent compared to that observed with
serum-solubilized curcuminoids (not shown).
The incubation conditions applied here denote increased
curcuminoid concentrations obtained with curcuminoid-saturated
serum. As a result, increasing curcuminoid concentrations were
also linked to higher serum concentrations. These conditions were
different from those employed for experiments described for Fig. 2,
where the total serum concentration was held constant at 5% and
the concentration of curcuminoid-saturated serum was varied.
The influence of serum on curcuminoid-binding to cells was
therefore explored at constant serum and variable curcuminoid
concentrations. NT2/D1 cells were incubated with media
containing increasing concentrations of curcuminoids (SO-
LID+DMSO) at constant total serum concentrations of 5%,
50%, or 100%. Within each of the three total serum concentra-
tions examined, the amount of cellular bound curcuminoids
increased linearly with the concentration of unbound curcumi-
noids. Comparable results were obtained with SOLID- and
DMSO-solubilized curcuminoids (not shown). This indicates that
cellular binding was not saturable within the parameters limited by
the maximum solubility of curcuminoids in serum. Furthermore,
the cellular binding of curcuminoids decreased with increasing
serum concentration, which is evident from a decline in the slope
of the binding curves as the serum concentrations increased
(Fig. 7B). These results were different from those obtained in
Fig. 7A, where binding saturation was observed when cells were
incubated with increasing amounts of curcuminoid-saturated
serum. This suggests that the additional curcuminoid-free serum
acts as a de facto competitor for cellular curcuminoid binding.
This notion was further confirmed by examining the effect of
increasing serum concentrations on cellular binding at a constant
47 mM (SOLID+DMSO) curcuminoid concentration in a total
initial 5% serum concentration (Fig. 7C). The data points were
best described by a hyperbolic decline function (R
2=0.97)
described by the equation:
y~
ab
xzb
This equation is consistent with the notion that free curcuminoids
in solution primarily exist in a complex with serum components
(C-S) that bind to cellular receptors (R) to form a curcuminoid-
receptor complex (C-R) illustrated by the equilibrium:
C{SzR<C{RzS
This yields the dissociation constant:
KD~
½C-S ½R 
½C-R ½S 
With [R]=[RT]-[C-R] and [S]=[ST]-[C-S], and rearranged:
½C-R ~
1=KD½C-S ½RT 
½ST z(1{KD=KD)½C-S 
When KD,,1, the term (1-KD/KD)R1/KD, and with [C-S] and
[RT] presumed to be constant, the equation assumes the form of
the original function used for curve fitting. Therefore, as the free
serum concentration increases, the curcuminoid-binding equilib-
rium is shifted from the cellular receptors to the serum complex.
Consequently, the availability of free serum in essence acts as
a competitor for curcuminoid-binding to cells.
Curcuminoids are Differentially Metabolized by NT2/D1
Cells
The fate of cellular-bound curcuminoids was further examined
by first allowing binding equilibrium to be established followed by
the removal of curcuminoids from the media. NT2/D1 cells were
therefore initially incubated with media containing 47 mM
curcuminoids (SOLID+DMSO) for 1 h. The cells were then
washed and incubated without curcuminoids for another 2 h
either with DMEM media alone or supplemented with 5% FCS.
The fate of cellular-bound curcuminoids was also examined under
subsequent cell-free conditions. In this case, cells were instead
incubated with 10 mM hepes, pH 6.8 at 37uC. This hypotonic
condition resulted in rapid swelling and rupture of cells, leaving
a suspension of membranes and cytoplasmic content.
During the 2 h incubation period, the amount of cellular-bound
curcuminoids declined rapidly. In cells incubated with DMEM
media without serum, the cellular-bound curcuminoids declined in
an essentially linear manner to a level of about 32% of the original
value. In serum-containing media, the drop in the level of cellular-
bound curcuminoids was more pronounced during the first 0.5
hour of incubation and the rate of decline slowed significantly
thereafter to reach a final level of about 20% of the original value.
Under cell-free conditions in hypotonic buffer, the decline in the
amount of membrane-bound curcuminoids was slower and also
essentially linear with time. At the end of the 2 h incubation time,
over 70% of the curcuminoids remained bound to the membrane
fraction (Fig. 8A).
Although the levels of all bound curcuminoids decreased during
incubation with DMEM media, the relative decline was more
rapid for BDMC and DMC than for CUR (Fig. 8A). This was also
reflected in a time-dependent increase in the level CUR and
a decrease in the levels of BDMC and DMC relative to the total
amount of bound curcuminoids (Fig. 8B). In contrast, the decline
in the levels of individual curcuminoids proceeded at the same rate
under cell-free conditions (Fig. 8A). These results suggest that
curcuminoids are actively metabolized by intact cells and that the
rate of metabolism is faster for BDMC and DMC than for CUR.
A parallel determination of the curcuminoid concentration in
cell culture media showed a rapid increase within the first 0.5 h of
incubation. The maximum curcuminoid concentration in serum-
containing media was about five-fold higher than in serum-free
medium and more than two-fold higher than in cell-free buffer
(Fig. 8C). More importantly, the curcuminoid composition differed
between serum-containing and serum-free media (Fig. 8D). In
serum-containing media, the curcuminoid composition was similar
to that of the original incubation medium (compare Fig. 1A, B,
right panel), whereas in serum-free media the curcuminoid
composition was similar to that of the cellular-bound curcuminoids
(compare Fig. 1C, right panel).
These results confirm that the cellular binding of curcuminoids
is at least partially reversible, which strongly suggests their
presence on the cell membrane (Fig. 6). With serum-containing
media, the original equilibrium is reestablished between cells and
curcuminoid-binding components of serum. In contrast, in serum-
free media the equilibrium is established between cellular-bound
curcuminoids and the aqueous media, resulting in a media
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cells. The higher concentration of curcuminoids in serum-contain-
ing medium would then be due to their higher solubility in serum.
The intermediate concentration in the cell-free supernatant may
reflect either curcuminoid binding to cytoplasmic components
following their release into the buffer or partial contamination with
small cell membrane fragments that did not sediment at 18,0006g.
The continued differential decrease in cellular-bound curcumi-
noids suggests active metabolism by intact cells, a notion that is
supported by the lack of similar decreases in cell-free incubations
(Fig. 8A).
Detection of Metabolic Products of Curcuminoids in
Media
Since no metabolic products could be detected by reversed
phase chromatography at an absorption wavelength of 427 nm,
the search for metabolic products in cells and incubation media
was further extended to include wavelengths 280 nm and 310 nm.
During incubation of NT2/D1 cells with media containing 47 mM
curcuminoids (SOLID+DMSO), absorption peaks with a similar
elution profile as the curcuminoid peaks at 427 nm were detected
at an absorption wavelength of 310 nm (Fig. 9A). These
compounds eluted faster, indicating higher polarity and they also
absorbed at 280 nm wavelength (not shown). These properties
suggested that the products were structurally related to curcumi-
noids and metabolically derived from the parent compounds. The
elution profile of the metabolic products was more similar to the
elution profile of curcuminoids bound to cells than that of the
medium (Fig. 9A). However, the metabolic products of BDMC
(B*) and DMC (D*) were relatively more prevalent in the medium
(26% and 28%, respectively) after 5 h of incubation than their
corresponding parental compounds (20% and 22%, respectively)
bound to cells. This implies that BDMC and DMC were
metabolized faster than would be suggested by their relative
cellular binding, which is consistent with the observation that these
compounds were in relative terms eliminated faster from cells and
media than CUR (Figs. 5 and 8A).
The curcuminoid metabolites were exclusively found in the
media and could not be detected in cells. Furthermore, these peaks
were absent in media without cells and their accumulation in the
media increased linearly in a time dependent manner over a 5 h
incubation period (Fig. 9B). Cells were incubated either with
47 mM saturated curcuminoids (SOLID+DMSO) in a total media
serum concentration of 5% (curve I), 24 mM saturated curcumi-
noids in a total media serum concentration of 2.5% (curve II), or
24 mM saturated curcuminoids diluted 1:1 with regular serum for
a total media serum concentration of 5% (curve III) (Fig 9B). In all
three cases, there was a linear accumulation of metabolic products
as a function of time (R
2.0.99), although the rate of accumulation
varied as reflected by the different slopes of the three curves. The
three incubation conditions also resulted in differences in the
amount of curcuminoids bound to cells. This was either due to
concentration-dependent (curves I and II) or serum-dilution effects
(curve III). Indeed, there is excellent agreement between the
accumulation of metabolic product in the media and the amount
of curcuminoids bound to cells after a 5 h incubation period
Figure 8. The dissociation of curcuminoids from NT2/D1 cells.
(A). Cells were incubated with media containing 47 mM curcuminoids
(SOLID+DMSO) for 1 h. The media were then removed and the cells
washed. Cells were then incubated either with 2 ml of DMEM alone (#)
or DMEM +5% FCS (N). Alternatively, cells were hypotonically lysed and
incubated with 2 ml of 10 mM hepes, pH 6.8 (&). The amount of
curcuminoids bound to cells was then measured during a 2 h period.
The numbers in brackets represent amounts of CUR (C), DMC (D) and
BDMC (B) relative to their respective starting concentrations (100%). The
values represent the average of three independent experiments with
standard deviations ranging from 3–8% (error bars omitted). (B) Elution
profiles of curcuminoids bound to cells at the start of incubation
(0 min) and after 30 and 120 min. The numbers in parentheses indicate
relative molar amounts of curcuminoids bound. (C) The concentrations
of curcuminoids released into the media after incubation as described
in A. (D) Elution profiles of curcuminoids in media after 30 min of
incubation in DMEM alone (-serum), in DMEM with 5% FCS (+serum)
and in 10 mM hepes, pH 6.8 (cell-free).
doi:10.1371/journal.pone.0039568.g008
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portional to the amount of curcuminoids bound to cells rather
than their concentrations in the media.
The faster elution times and the loss of absorption at longer
wavelengths compared to the parent compounds suggested
reductive modifications within the conjugated keto-enol linker
region of the curcuminoids. For structural assessment, the peak
corresponding to the metabolic product of CUR was collected and
further analyzed by mass spectrometry. This generated a com-
pound with a molecular mass of 371, which was identical to that of
tetrahydrocurcumin. However, a direct comparison with tetra-
hydrocurcumin revealed that the mass spectra of the two
compounds were different although they shared some overlapping
features. Furthermore, the spectral absorption of the two
compounds differed. While tetrahydrocurcumin only absorbed at
280 nm, the curcuminoid metabolic products showed a higher
absorption at 310 nm wavelength. More importantly, the elution
peaks of the two compounds did not overlap. This indicated that
the metabolic product identified here was different from tetra-
hydrocurcumin. It should here be noted that the elution peaks
produced by hexahydrocurcuminoids, overlap extensively with the
alternative metabolic products described here (Fig. 10). However,
the absorption maxima do not align perfectly and hexahydro-
curcuminoids do not absorb at 310 nm wavelengths. Based on the
observations from mass spectrometry and the absorption char-
acteristics of the compounds, the metabolic product of curcumin
(C*) was tentatively assigned the structure 1,7-bis(4-hydroxy-3-
methoxyphenyl)-5-hydroxy-1-heptene-3-one (Fig. 9C). The re-
maining carbon-carbon double bond within the aliphatic linker
thus forms a more extended conjugated double bond system with
the remaining keto-group than is the case in tetrahydrocurcumin,
and the compound is therefore expected to absorb at longer
wavelengths. However, the ultimate structure assignment would
need to be confirmed by NMR.
The presence of metabolites in the incubation media was also
assessed in CCF-STTG1 and HeLa cell cultures. After 24 h of
incubation, the primary metabolites generated by CCF-STTG1
cells were hexahydrocurcuminoids together with smaller amounts
of octahydrocurcuminoids (Fig. 10A). In contrast, HeLa cells
generated no octahydrocurcuminoids (Fig. 10B). However, in
addition to hexahydrocurcuminoids, HeLa cells also produced
some of the same C*, D*, and B* metabolic products observed
with NT2/D1 cells (Fig. 10C). Although HeLa and CCF-STTG1
cells produced primarily hexahydrocurcuminoids after exposure to
curcuminoids for 24 h, the C*, D*, and B* metabolic products
featured more strongly during the early stages (,5#h) of
incubation (not shown). These results indicate that cell lines
differentially metabolize curcuminoids and the metabolic products
may reflect the tissue of origin of the cell line.
The Biological Effects of Curcuminoids can be Elicited by
Short-term Exposure to High Concentrations of
Curcuminoids
The described data (Figs. 2, 3, 4) show that continuous exposure
of NT2/D1 cells to curcuminoids caused distinct biological
responses in a dose-dependent manner. In those experiments,
cells were exposed to varying initial concentrations of curcumi-
noids for a period of 24 h before being replenished with fresh
medium. However, subsequent experiments on cellular binding
and media depletion suggested that the cells actively metabolized
curcuminoids, resulting in a decline in cellular-bound curcumi-
noids during the 24 h time period. There was also limited
chemical decomposition of curcuminoids, independent of the
presence of cells. As a result, the initial starting curcuminoid
concentrations in the media were transient and significantly
decreased during the 24 h incubation period. The experimental
conditions therefore more accurately reflected exposure to
successive starting concentrations of curcuminoids that were
restored every 24 h. Consequently, it might be expected that
Figure 9. Metabolites of curcuminoids detected in incubation
media. (A) NT2/D1 cells were incubated with media containing 47 mM
curcuminoids (SOLID+DMSO) for 5 h. Left panel: The elution profile at
310 nm wavelength of metabolites derived from BDMC (B*), DMC (D*),
and CUR (C*) in the media. Center and right panels: The elution profiles
at 427 nm wavelength of curcuminoids extracted from cells and media,
respectively. The relative areas under the curve of each peak are
indicated in square brackets. (B) Time course of the generation of
curcuminoid metabolites (OD at 310 nm wavelength) in the media
under three incubation conditions: Incubation of cells with 47 mM
curcuminoids in 5% FCS (I, &), with 24 mM curcuminoids in 2.5% FCS (II,
#), or with 24 mM curcuminoids in 5% FCS (III,N). Insert: The value of
the slope (m) of curve II (I/II, hatched bar) and III (I/III, hatched bar)
relative to the value of the slope of curve I (I/I, black bar). The resulting
ratios were similarly compared to the ratios of curcuminoids bound to
cells (b, solid bars) after 5 h under the same respective incubation
conditions (C) Putative structure of the metabolic product of CUR (C*)
based on the evaluation of mass spectrometry and absorption
properties.
doi:10.1371/journal.pone.0039568.g009
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media were replenished more often or even continuously.
Alternatively, similar responses might be elicited by transiently
exposing cells to higher curcuminoid concentrations. To examine
this possibility, cells were incubated with 47 mM curcuminoids
(SOLID+DMSO) for 0.5 h, 1 h, 2 h, and 4 h. Thereafter, cells
were washed with PBS and incubated with curcuminoid-free
standard medium. Cells were then monitored for 4–8 days to
detect changes in the rate of cell division and evidence for
morphological changes or senescence. When cells were exposed to
47 mM curcuminoids for 0.5 h and 1 h, cell proliferation initially
decreased for a period of 1–3 days after exposure. Thereafter, the
rate of cell division resumed at normal levels, however with lower
starting cell numbers than the untreated control. No evidence of
significant cell death was observed at these exposure times. When
NT2/D1 cells were exposed to curcuminoids for 2 h, some limited
cell death was observed and the recovery of normal cell division
was delayed to 5–7 days after exposure (Fig. 11A). The transient
appearance of a larger cell type reminiscent of the morphology
illustrated in Fig. 4 was also apparent during the first two days
after curcuminoid exposure (not shown).
Significant cell death occurred within the first 24 h after
exposure curcuminoids for 4 h. The cell number stabilized at
a level of about 5% of the original value by 2 days after exposure
(Fig 11B). During the following days some cell division resumed.
However, the dividing cells did not immediately assume the
phenotype of untreated cells. Instead, they were larger and they
migrated to distribute themselves more evenly over the available
growth surface (Fig. 11B, day 5, arrows). Indeed some of these cells
further enlarged to assume what was reminiscent of the senescent
phenotype (arrowheads) described in Fig. 4. On day 6 after
exposure, some of the dividing cells showed evidence of reverting
to the untreated phenotype. They were smaller and no longer
mixed with the surrounding cell population (brackets). These cells
became more numerous on day 7 and day 8 and formed rapidly
dividing colonies with defined boundaries that expanded by
crowding out existing populations of larger cells. During the next
few days these cells completely overgrew the culture dish.
These results suggest that the same cellular effects that were
obtained by chronically exposing NT2/D1 cells to lower
concentrations of curcuminoids, could also be obtained by
exposing cells transiently to a higher curcuminoid concentration.
The main difference being that the effects were temporary and,
with the exception of induced cell death and terminal differenti-
ation, a subpopulation of cells recovered to their original state.
The amount of time required for recovery was dependent on the
curcuminoid exposure time.
Discussion
The human embryonal carcinoma cell line NT2/D1 is a single-
cell clone derived in multiple steps from a parental line designated
as Tera-2 [25]. NT2/D1 cells are considered pluripotent and are
in that respect similar to embryonic stem cells [26]. In contrast to
stem cells, these cells are malignant and they contain karyotype
abnormalities including polyploidy and chromosomal transloca-
tions [25]. However, similar rearrangements are also to varying
degree found in most other cancer-derived cell lines. In addition,
proteomic comparison of the cell membrane composition between
embryonic stem cells and NT2/D1 cells revealed unique features,
but also extensive similarities [26]. For comparative purposes with
respect to the effects of curcuminoids, NT2/D1 cells should be
considered a cancer cell line with some features in common with
normal embryonic cells.
The effect of curcumin on cell division has been the subject of
extensive studies with numerous cell lines and primary cells [27].
Curcumin induces growth arrest at various phases of the cell cycle,
including G1/S, S, and G2/M. This is accomplished by
Figure 10. Metabolites of curcuminoids in different cell lines.
(A) CCF-STTG1 cells were incubated with media containing 47 mM
curcuminoids (SOLID+DMSO) for 24 h. During reversed phase chroma-
tography of media samples, the elution profiles were monitored at
wavelengths 280 nm (hatched lines), and 310 nm (solid lines).
Prominent absorption peaks representing hexa- and octahydrocurcu-
minoids were detected at 280 nm wavelength. (B) Primarily hexahy-
drocurcuminoids were produced with similarly incubated HeLa cells, in
addition to smaller amounts of curcuminoid reduction products C*, D*,
and B*. (C). In contrast, NT2/D1 cells generated only reduction products
C*, D*, and B*.
doi:10.1371/journal.pone.0039568.g010
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ed by e.g. NFkB [22,23,28,29,30,31,32,33,34,35,36,37], Akt
[33,36,38,39], and NrF2 [40,41,42,43,44,45]. These in turn affect
the expression of gene products such as among others COX-2,
cyclins, Bcl-2, and p53, thereby ultimately reducing or abolishing
cell division (for reviews and additional references:
[46,47,48,49,50,51,52]). The results presented here are qualita-
tively consistent with those observations. Curcuminoids diminish
NT2/D1 cell division in a dose dependent manner upon repeated
exposure to curcuminoids at 1–5 mM initial concentrations
(Fig. 2A). Reports from other studies on the inhibition of cell
division or cell survival following curcumin exposure vary over
a wide curcumin concentration range. In cases where IC50 values
for cell proliferation or viablility were determined for a variety of
cancer cell lines, these ranged from 2.5–170 mM after curcumin
exposure times of 24–120 h. Comparative values for primary cells
ranged from 2.8 to .1000 mM (Table 2). However, in most
reports curcumin was added as a single initial dose and not
replenished before the time of analysis. It is therefore difficult to
compare those studies with the results reported here, where
curcuminoids were regularly replenished every 24 h. Indeed,
comparable IC50 values for NT2/D1 proliferation would be about
2.3 mM after 96 h or 3.8 mM after 48 h of exposure. These values
would likely be higher after a single application of curcuminoids,
since these would be depleted after 24 h (Fig. 5). However, it is
clear that different cell lines vary in their sensitivity to curcumin.
For example, HeLa cells can be repeatedly exposed to more than
10 mM curcuminoid concentrations without apparent cell death
under the same conditions as those applied here [13] (Table 1).
The reasons for these different responses remain to be determined,
but they may be related to the configuration of cellular sites
available for curcuminoid binding and their role in the regulation
of cell division. Although the effects of curcuminoids on normal
cells were not examined in this study, it may be noted that
a number primary cells from different tissues are sensitive to the
effects of curcumin, albeit at generally higher concentrations than
is typically the case for cancer-derived cell lines (Table 2).
Furthermore, curcumin inhibits the proliferation of human retinal
endothelial cells at concentrations of 1–30 mM [53]. Curcumin
also inhibits cell division in mouse oocytes and early embryonic
development at concentrations of ,50 mM [54]. In a different
study, significant apoptosis and inhibition of cell division was
reported at the mouse blastocyst stage at a 24 mM curcumin
concentration [55]. Survival of zebra fish embryos and larvae was
also impaired after a 24 h exposure to curcumin with respective
LD50-values of 7.5 mM and 5 mM [56]. These results suggest that
the effects of curcumin on normal cells may not be as benign as
generally presumed.
At higher initial curcuminoid concentrations (.8 mM), exten-
sive NT2/D1 cell death occurs within two days of exposure (Fig. 2).
At 46–49 mM curcuminoid concentrations, cell death is largely
due to apoptosis via the activation of caspase 3/7 by both extrinsic
(caspase 8) and intrinsic pathways (caspase 9). In this respect, these
results are consistent with those reported for other cell lines at 20–
100 mM curcumin concentrations [36,57,58,59,60] and for mouse
embryos at 6–24 mM concentrations [55]. However, in NT2/D1
Figure 11. Effect of incubating NT2/D1 cells for short time periods with high concentrations of curcuminoids. (A) Cells were either
incubated with standard medium (N) or with medium containing 47 mM curcuminoids (SOLID+DMSO) for 0.5 h (#), 1 h (&), 2 h (%), or 4 h (m). The
media were then removed, cells washed, and replenished with standard medium. Cells were photographed and counted daily. (B) Phase contrast
micrographs of NT2/D1 cells before (day 0) and 2, 5, 6, 7, and 8 days after incubation with 47 mM curcuminoids for 4 h. Arrows point to larger dividing
cells and arrowheads to cells reminiscent of a senescent phenotype. Brackets delineate groups of cells that have reverted to the original phenotype
(compare Fig. 3).
doi:10.1371/journal.pone.0039568.g011
Table 2. Curcumin effect on cell proliferation.
CELLS
1 TIME
2 (H) IC50 (mM) REFERENCE
M21 48 19.05 [93]
SP6.5 22.39
B-NHL 36 24.1 [94]
SK-NEP-1 48 4 [95]
PBMC* 48 2.8* [96]
HeLa 48 14.32 [97]
Leiomyoma 48 10–15 [98]
Myometrial* 40*
DLD-1 72 23.88 [99]
HCT-116 7.95
SW480 6.49
K562 48 41.89, 54.3 [100,101]
MCF-7 n.s. 10.44 [102]
NCI-H460 20.6
DU-145 27.6
HepG2 48, 24 15.8, 13.95 [103–106]
MCF-7 48 24.8, 40
MDA-MB-231 48, n.s. 11, 30
Hs-68* 48 .50*
C32 96–120 6.1–7.7 [107]
G-361
WM266-4
Osteosarcoma cell lines
(6)
72 14.4–24.6 [108]
HF4.9 48 11.3 [109]
HF1A3 9.8
HF28RA 7.5
BT16
A204
G401
72 8.12
6.4
5.21
[110]
22rv1 24 44 [66]
LNCaP 48
DU145 170
PC-3 115
Pancreatic Carcinoma
cell lines (6)
72 2.5–37.8** [29]
Colon cancer
cell lines (3)
72 10.21–13.31 [111]
WI-38* 48.38*
Pancreatic carcinoma
cell lines (5)
72 5.6–20.35 [112]
Bladder cells* .1000*
1Assorted cell lines and primary cells.
2Exposure time to curcumin before analysis.
*Primary cells, **Liposomal formulation, n.s.-not specified.
doi:10.1371/journal.pone.0039568.t002
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higher levels of curcuminoids (Fig. 4). This includes caspases 1,4
and 5, which are activated by extracellular inflammatory stimuli
[61]. Caspase 2 is considered to be another initiator caspase whose
function remains undetermined, whereas caspase 10 is functionally
related to caspase 8. Finally, caspase 6 is an effector caspase with
a different substrate specificity from caspases 3/7 [62]. Although at
higher curcuminoid concentrations there is a universal activation
of caspases in NT2/D1 cells, the dose-dependent cellular response
to curcuminoids suggests that caspase activation may be similarly
differentially regulated. In particular since caspases also have
a function in cellular proliferation and differentiation [63,64].
Although caspase-dependent apoptosis is a prominent feature at
high curcuminoid concentrations, alternative mechanisms of cell
death such as autophagy [38,65,66] or other caspase-independent
pathways [67,68] have been described.
Despite structural evidence of apoptosis and caspase activation,
nucleosomal DNA fragmentation could not be demonstrated in
NT2/D1 cells exposed to curcuminoids. In contrast, apoptosis
induction by camptothecin did show concomitant DNA fragmen-
tation indicating that this result was not due to methodological
reasons. This phenomenon may indeed be cell-type specific since
variable induction of DNA fragmentation was observed in
leukemia and fibroblastic cell lines [69]. Lack of DNA fragmen-
tation was also observed in Jurkat cells and and primary T-cells.
This was interpreted as the direct inhibition of the CAD
endonuclease by the binding of curcumin to the active site
[58,60]. However, CAD activation by caspase 3 occurs in the
nucleus [70] and significant nuclear localization of curcumin has
generally not been observed by histological methods
[22,23,66,71]. Nevertheless, at least one study has reported some
degree of nuclear localization both by fluorescence microscopy
and differential centrifugation [72]. It is therefore conceivable that
a sufficient amount of curcuminoids are present in the nucleus to
achieve CAD inhibition, or that under apoptotic conditions there
is a different distribution of curcuminoids within cells due to
altered exposure of subcellular compartments.
At intermediate curcuminoid concentrations (6–7 mM) a limited
degree of cell death is observed and the remaining NT2/D1 cells
gradually develop a phenotype that is consistent with senescence
(Fig. 3). Cellular senescence is often induced by external stress
signals such as hypoxia or by the action of cytokines [73,74]. These
in turn induce the production of reactive oxygen species either at
the cytoplasmic level or in the mitochondrial transport chain. In
particular in human cells, the activation of the p16INK4A/rb
signaling pathway leading to the irreversible cessation of cell
division has been implicated in the induction of senescence
[75,76,77]. The observation that only a subpopulation of cells
comprising about 40–50% of the original number (Fig. 2)
developed into a senescent phenotype (Fig. 3), suggests that this
may not be a random process. Since NT2/D1 cells are not
homogeneous in terms of chromosome distribution, it is conceiv-
able that some of the cells express biomarkers that make them
more susceptible to cell death upon exposure to intermediate
curcuminoid concentrations. In addition, the initial change in
morphology in the remaining cells (Fig. 3) may indicate a form of
cellular differentiation, which is consistent with the notion that this
cell line can be induced to differentiate into various ectodermal cell
types [14]. This concept may be extended to other cancer cell
lines. For example, at intermediate curcuminoid concentrations
a majority CCF-STTG1 cells showed robust differentiation into
a phenotype resembling astrocytes before progressing to senes-
cence. In contrast, only a minority of HeLa cells exhibited similar
signs of differentiation and senescence (not shown). These variable
effects among dedifferentiated cancer cell lines may again reflect
the distribution of cells within the total population with biomarker
profiles that designate them either for cell death or differentiation
at intermediate curcuminoid concentrations.
There is a concentration-dependent gradient of biological
effects of curcuminoids on NT2/D1 cells ranging from a decrease
in the rate of cell division to cell death by apoptosis. Since most of
these events can be accounted for by the interaction of
extracellular signals on cell membrane receptors, it is not
surprising that curcuminoids bind preferentially to membrane-
associated fractions (Fig. 6). Although it has not been proven that
the cell membrane is the primary target for curcuminoid binding,
it is reasonable to assume that it is the initial target, in particular,
in view of the rapid dissociation of non-metabolized curcuminoids
from the cells following their removal from the medium (Fig. 8).
Data based on fluorescence microscopy seem to suggest that
curcumin also accumulates intracellularly [22,23,66]. Although
fluorescence microscopic resolution does not appear to be
sufficient to clearly differentiate between cell membrane and
intracellular distribution, a study using confocal microscopy to
determine curcumin localization concluded that curcumin almost
exclusively partitioned into membrane structures [71]. A different
study employing differential centrifugation also showed preferen-
tial binding to membrane fractions [72]. However, Kunwar et al.
[72] used 0.6% Nonidet P-40 to disrupt cells. Even at such
a concentration, this detergent substantially increases the solubility
of curcumin, which is likely to dislodge membrane bound
curcumin during extraction and fractionation. This would explain
the significantly larger proportion of curcumin recovered from the
cytoplasmic fraction in that study compared to the very low levels
of cytoplasmic curcuminoids reported here (Fig. 6). Another study
employed sonication as a method of cell disruption [78]. Cells
were then centrifuged at 9,0006g and the supernatant was further
centrifuged at 100,0006g. This resulted in total amounts of
curcumin 2–3 times higher in the 100,0006g membrane pellet
than in the cytosolic supernatant, although the amount bound to
the initial 9,0006g pellet was not reported.
The cellular sites that are targets for curcuminoid binding
remain largely unknown. However, they are likely to be numerous
with varying individual binding affinities. Consequently, the
overall KD values for specific cellular binding of curcuminoids
determined here are not to be considered as representing the
affinity for a single binding site. Instead, they represent the sum of
numerous binding sites with similar curcuminoid binding affinities.
Protein components embedded in the membrane such as cellular
receptors, a wide variety of which have been identified in NT2/D1
cells [26], seem to be likely targets. In particular, since curcumin
has been shown to interact with proteins, including albumin and
numerous mediators of cellular transduction (for references see:
[79]). However, direct binding of curcuminoids to the exposed
polar moieties of membrane lipids is also likely. This clearly has
implications in the context of membrane compartmentalization
into lipid rafts [80]. The binding of curcuminoids to such ordered
lipid-protein assemblies could affect both signal transduction
events and provide an avenue for internalization [81]. Indeed,
lipid raft and receptor mediated endocytosis has been described for
the cellular uptake of resveratrol, a biochemically and functionally
related polyphenol [82].
The overall KD for total specific binding of soluble curcumi-
noids to NT2/D1 cells was here determined to be in the 6–10 mM
range using variable amounts of curcuminoid-saturated serum
(Fig. 7). These KD values are based on cellular binding versus the
concentration of total soluble curcuminoids, which are primarily
present as complexes with serum components under saturating
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concentrations necessary to induce biological effects, actual
cellular binding under the employed experimental conditions of
variable curcuminoid and constant serum concentration would be
considerably lower due to competition for cellular binding by free
serum (Fig. 7). This also has therapeutic implications, since in vivo
the lower degree of cellular curcuminoid binding in the presence
of excess serum would further limit the cellular response at an
already low level of bioavailability. The situation is further
complicated by the observation that there are at least two different
binding sites for curcumin on serum albumin [83], which is
a primary curcuminoid-binding component in serum [13,84].
Indeed, the stoichiometric ratio of curcuminoids/albumin at
binding saturation suggests the presence of at least three potential
albumin binding sites [13]. It is likely that the albumin-bound
curcuminoids are released sequentially for binding to cellular
receptors. It is also plausible that the serum- or albumin-bound
curcuminoids occupy different binding sites, depending on
whether they are SOLID- or DMSO-solubilized. Upon mixing
such saturated preparations, intermolecular rearrangements could
occur leading to a redistribution of curcuminoid binding sites
within the serum that would have a similar competitive effect as
adding curcuminoid-free serum. This would then result in an
increase in the overall apparent KD for cellular binding as was
observed for albumin and serum solutions (Fig. 7). Consequently,
differences in apparent KDs for cellular binding resulting from
using different soluble curcuminoid preparations would not
represent variable affinities for cellular receptors, but rather
varying affinities for curcuminoid-binding to serum components.
A comparison of the cell lines NT2/D1 (embryonal carcinoma),
HeLa (cervical carcinoma), and CCF-STTG1 (astrocytoma),
shows that these cells differ in their rate of cell division, their
affinities for curcuminoids, and their response to curcuminoids
(Table 1). The cellular responses to curcuminoids in the form of
cell death and senescence are related to the cellular affinities for
curcuminoids. The reasons for these differences in cellular
affinities for curcuminoids between cell lines are currently unclear.
However, they are likely associated with the lipid and protein
organization within the cell membranes of the different cell lines.
As a result, the cellular affinity and response to endogenous or
serum-derived growth factors may also vary, resulting in different
rates of cell division.
Although differential effects of individual curcuminoids on
a variety of biological responses have been reported (review: [2]),
it did not matter in these experiments whether the curcuminoids
solubilized in FCS contained either predominantly CUR (DMSO-
solubilized) or BDMC (SOLID-solubilized). The effects on cell
division, apoptosis, induction of senescence, or activation of
caspases were indistinguishable for the two preparations within
the limits of the established experimental parameters. This could
be because the two preparations contained a complement of all
curcuminoids, albeit at different relative abundance, and as such
the experimental design did not allow for a sufficient resolution to
detect differential effects. In addition, the lack of difference may
be explained by the different properties of curcuminoids in
solution and in terms of binding and metabolism. Although
BDMC and DMC have higher apparent binding affinities for
cellular receptors, they are also metabolized at a relatively faster
rate, resulting in a faster depletion from cells and media (Figs 5
and 8). Conversely, over a 24 h period CUR is more readily
subject to chemical decomposition than BDMC or DMC
[13,24,85]. Overall, the sum of these effects may neutralize any
differential biological effects of the individual curcuminoids in
these preparations.
Curcuminoids bound to cell membrane receptors could act on
signal transduction pathways by either blocking the access of
growth factors present in the serum or by inducing cellular
responses themselves. However, simply reducing or eliminating
the serum in the media does not produce responses similar to those
induced by curcuminoid exposure. Indeed, reducing serum
concentrations to 1% merely resulted in a moderate decrease in
the rate of cell division. Completely eliminating the serum induced
extensive cell death within 24 hr while the induction of senescence
could not be demonstrated at any serum concentration (not
shown). Furthermore, exposing NT2/D1 cells to high concentra-
tions of curcuminoids for shorter time periods of 0.5–4 h resulted
in cellular responses similar to those obtained with chronic
exposure at lower concentrations (Fig. 10). These observations
suggest that curcuminoid-binding to cells activates signal trans-
duction pathways that lead to dose- or time-dependent reductions
in cell division, induction of senescence, or apoptosis. Indeed,
curcumin has been identified as an activating ligand for the
vitamin D receptor (VDR) [86], which is also highly expressed in
NT2/D1 cells [87]. The intracellular VDR could potentially be
accessed by curcuminoids via the same cell membrane receptor- or
caveolae-mediated mechanisms that are also used to transport
steroid hormones [88]. That curcuminoid binding per se is
responsible for these effects is further exemplified by the
observations that presumably inactive metabolites such as those
described here (Fig. 9), and conjugated products such as curcumin
sulfate (not shown) or glucuronidate [78] show no significant
cellular binding. Similarly, upon incubating cell cultures with
hexahydrocurcumin, the metabolite was found in the cytosolic but
not in the membrane fraction [78], indicating a general loss of
membrane binding upon curcumin reduction. It is indeed likely
that the poor solubility of curcumin in water is a crucial property
that forces it to be shuttled between amphophilic binding sites in
serum components and the cellular binding sites, a property also
shared by steroids and related compounds.
The primary metabolic reduction products of curcumin in vivo,
in tissue slices, and in cell extracts are tetrahydrocurcumin and
hexahydrocurcumin with smaller amounts of dihydrocurcumin
and octahydrocurcumin, a conversion that takes place primarily in
the liver and intestine [78,89,90]. Hexahydrocurcumin has also
been identified in cultured Ishikawa and HepG2 cells [78]. In this
study, hexahydrocurcuminoids were identidied as the major
metabolites in both HeLa and CCF-STTG1 cells, while the latter
also generated significant amounts of octahydrocurcuminoids
(Fig. 10). However, none of those reduction products were
identified in NT2/D1 cells. Instead, novel curcuminoid reduction
products with the same molecular weight as tetrahydrocurcumi-
noids but with different spectral and chromatographic elution
properties were detected (Fig. 9). The preliminary structure
assignment of these compounds shows different positions of the
remaining double bonds compared to tetrahydrocurcumin. The
same conversion products were initially also found in the
astrocytoma cell line CCF-STTG1 and in HeLa cells upon
shorter incubation times (,5 h) and are thus not unique to NT2/
D1 cells (not shown). This shows that at least in culture, an
alternative reduction pathway is available to inactivate curcumi-
noids. Whether this also exists in vivo remains to be established.
The enzymes responsible for the reductive conversion have not
been identified, but at least in vitro it can be accomplished with
alcohol dehydrogenase [89]. In any case, most reductases are
cytoplasmic enzymes and consequently it would require the
curcuminoids to be internalized after binding to the cell
membrane. The resulting curcuminoid reduction products would
then loose their membrane binding properties upon which they
Curcuminoid Binding to Embryonal Carcinoma Cells
PLoS ONE | www.plosone.org 16 June 2012 | Volume 7 | Issue 6 | e39568are expelled into the medium. That this is an efficient process is
suggested by their lack of detection in cells.
In conclusion, this study has described the cellular binding and
metabolic fate of curcuminoids. While focusing primarily on NT2/
D1 cells as a model system, selected binding parameters and
cellular effects were also compared to HeLa and CCF-STTG1
cells. For this purpose, commercial grade curcumin was first
solubilized in FCS at saturating concentrations in the 1 mM
range. As a result, maximal curcuminoid concentrations of about
50 mM can be achieved in culture media containing 5% total FCS.
This method of solubilization is different from that typically
employed in other studies, where curcumin is dissolved in an
organic solvent and added at appropriate dilutions to the final
culture medium. Directly solubilizing curcuminoids in serum offers
several advantages over adding curcuminoids dissolved in organic
solvents. These include the lack of initial precipitation, lower
overall concentrations of organic solvents, and greater precision in
achieving small increments of curcuminoid concentrations in the
media. The lack of precipitation is particularly relevant to studies
where curcuminoid concentrations in excess of 100 mM are
employed with media containing 10% FCS. Since the vast
majority of soluble curcuminoids are complexed with FCS, any
excess beyond the saturation point will remain in the media as
particulate matter with unknown consequences in terms of
binding, metabolism and biological effects. Furthermore, com-
mercial grade curcumin can be solubilized in serum by two
procedures resulting in similar total concentrations but profoundly
different final compositions. Direct mixing of such solutions at
different ratios thus easily generates preparations with a range of
curcuminoid profiles. This has allowed for the titration of their
biological effects at curcuminoid concentration increments of
about 1 mM in the media. Future projects will address the
modulation of specific signal transduction pathways using the same
range of curcuminoid concentrations that result in reduced rates of
cell division, induction of senescence, and cell death. Based on
such data, it should be possible to correlate specific biological
responses with the incremental binding of curcuminoids to cells
and specific signal transduction events. Given a sufficient resolu-
tion, this could help clarify the sometimes conflicting data that has
emanated from the large body of literature encompassing
curcumin research.
Materials and Methods
Standard Reagents and Solutions
Technical and analytical grade curcumin were obtained from
the Cayman Chemical Company. Technical grade curcumin
(.65%) contains all three curcuminoids whereas analytical grade
curcumin is highly enriched in CUR (.90%) together with small
amounts of DMC. Pure synthetic CUR was provided by Dr.
Francis Johnson. DMSO [ACS reagent], BSA [Fraction V, 96–
99% albumin] were obtained from Sigma Chemical Company.
DMEM, 4.5 mM glucose [Lonza], 1-butanol (HPLC grade),
Acetonitrile and water (both HPLC grade) were purchased from
Fisher Scientific and Trypsin-EDTA (0.05%) from GIBCO. FCS
was supplied by Aleken Biologicals. Tetrahydrocurcumin and
octahydrocurcumin used as standards for reversed phase chroma-
tography and mass spectrometry were obtained from the Sabinsa
Corporation and hexahydrocurcumin from Sigma-Aldrich. All
other standard laboratory chemicals were provided by Research
Organics.
BSA was prepared as a 10% (w/v) stock solutions in PBS
(137 mM NaCl, 10 mM Phosphate, 2.7 mM KCl, pH 7.4). Sera
were thoroughly mixed and used as provided. Autoclaved isotonic
(0.9% w/v) or hypotonic saline (0.6% w/v) solutions were
prepared with deionized water. Butanol for curcuminoid extrac-
tion was equilibrated with an excess of deionized water containing
1 mM hydrochloric acid and used after phase separation.
Curcuminoid Solubilization and Cell Culture Media
Preparation
For cell culture media preparation, 25–50 mL of FCS was
either mixed with solid curcuminoids (SOLID-solubilized, 50 mg/
mL) or with 5 ml/mL of curcuminoids predissolved in DMSO at
a 1 M concentration (DMSO-solubilized). In both cases, the
suspended curcuminoids were stirred in 50 mL Erlenmeyer flasks
at 4uC for 16–24 h. Residual insoluble curcuminoids were
removed by two successive centrifugations at 20,0006g followed
by sterilization through 0.45 mm filters [13]. In some procedures,
the SOLID- and DMSO-solubilized curcuminoid-saturated FCS
was mixed at a ratio of 1:1 (SOLID+DMSO). Curcuminoid-
containing media were diluted with standard medium (DMEM
supplemented with 5% FCS) to obtain the desired final
curcuminoid concentrations.
The Effects of Curcuminoids on Cell Division and Survival
NT2/D1 cells (ATCC#: CRL-1973) were grown in 5.6 mL
standard medium at 37uC in an incubator equilibrated with 5%
CO2. To investigate the effect of increasing curcuminoid
concentrations on cell division and survival, cells were seeded at
about 20% confluence (,1.2610
6 cells) in 25 cm
2 flasks (Sarstedt).
The following day (day 0), the standard medium was replaced with
media containing 1–10 mM SOLID- or DMSO-solubilized
curcuminoids. HeLa (ATCC#: CCL-2) and CCF-STTG1
(ATCC#: CRL-1718) cells were similarly incubated, albeit at
higher (10–30 mM) curcuminoid concentrations due to the re-
duced curcuminoid sensitivities of these cell lines.
In instances where NT2/D1 cells were transiently exposed to
higher curcuminoid (SOLID+DMSO) concentrations, the stan-
dard medium was replaced with curcuminoid-containing media
(47 mM) on the day after seeding (day 0) and incubated for 0.5 h,
1 h, 2h, and 4 h. Thereafter, the curcuminoid-containing medium
was removed and the cells washed twice with 6 mL of standard
medium followed by incubation for 1–8 days in 6 mL of standard
medium. In all cases, the media were changed every 24 h and the
cells photographed and counted for 1–8 days. If necessary, cells
were diluted and subcultured at a ratio of 1:5 upon reaching
confluence.
Reversed Phase Chromatography
Curcuminoids were extracted from cells and media with
acidified water-saturated butanol. The butanol was evaporated
in a Savant Speed-Vac concentrator attached to a vacuum pump.
The dried residue was reconstituted in a 0.2–3.6 mL solution
(FPLC loading buffer) containing 75% eluent A (5% acetonitrile,
0.01% ammonium acetate, pH 4.5, and 95% water) and 25%
eluent B (95% acetonitrile, 0.01% ammonium acetate, pH 4.5,
and 5% water), yielding a final acetonitrile concentration of
27.5%. Reversed phase chromatography was performed on an
FPLC A ¨KTA Purifier system equipped with a Source 5RPC ST
4.6/150 column (GE Healthcare). Reconstituted curcuminoids
(0.2–3.6 mL) were loaded onto a 0.1 mL sample loading loop and
separated with a 35 mL linear gradient, which ranged from
a starting concentration of 75% eluent A and 25% eluent B to
a final concentration of 15% eluent A and 85% eluent B (27.5%–
81.5% acetonitrile) at a flow rate of 1 mL/min. The eluent was
monitored at wavelengths of 280, 310, and 427 nm. Quantitation
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integration program (version 5.10).
Cell Numbers, Concentration Calculations, and Statistical
Analysis
NT2/D1 cells were photographed in three random viewing
fields using phase contrast microscopy and manually counted.
Alternatively, a dose curve was created that correlated cell number
and total protein content. Linearity extended up to 10
7 cells/
25 cm
2 flask with 1 mg of protein representing 6.35610
6 cells (not
shown).
Curcuminoids were separated by reversed phase chromatogra-
phy and quantitated based on a standard curve for curcumin
(analytical grade) by integration of the peaks with the FPLC
Unicorn (version 5.10) program (Pharmacia-GE). The molar
absorptivities (e) of the three curcuminoids dissolved in ethanol
were previously shown to range from 6.73 (610
4 Lc m
–1mol
–1) for
CUR, 5.78 for DMC and 4.95 for BDMC at 425 nm [91]. Since
the molar absorptivity for curcumin dissolved in butanol was
essentially the same as in ethanol (not shown), the integrated values
of the DMC and BDMC peaks were multiplied by the respective
factors 1.17 and 1.36 to obtain molar concentrations in all
experiments, except for those relating to the identification and
quantitation of curcuminoid metabolites. In those cases, the area
under the peaks was used directly for comparative purposes.
Unless otherwise indicated, all data points were calculated as the
average of 3–10 independent experiments, each assayed in
duplicate. Error bars represent the standard deviation from the
average. In the case of dose curves, individual data points were
combined from at least three separate experiments and the
integrity of the data is indicated by the associated R
2-values of the
curve fit (Sigmaplot, version 11).
Caspase and DNA Fragmentation Assays
For the determination of caspase activities, NT2/D1 cells were
grown in 75 cm
2 flasks to 90% confluence (,2610
7 cells). Cells
were then either harvested directly (time 0 h) or exposed to 46–
49 mM curcuminoids in 5% FCS in a total volume of 12 mL for 6,
12, or 18 h. Cells were scraped directly into the incubation media
and centrifuged at 5,0006g for 5 min. The pellets were
resuspended in 1 mL of PBS, transferred to 1.5 mL microfuge
tubes and centrifuged at 12,0006g for 1 min. The pellet was
washed twice with 1 mL of PBS. The final pellet was assayed for
caspase activity with a colorimetric assay kit (BioVision). Each
pellet was resuspended in 300 ml cell lysis buffer and left on ice for
5 min. The lysed cells were centrifuged for 10 min at 14,0006ga t
4uC to pellet nuclei and membranes. The supernatants were
carefully removed and transferred to fresh microfuge tubes. For
caspase assays, the supernatants were aliquoted in volumes of
50 mL to 5 fresh microfuge tubes containing either 1 mL DMSO
(blank) or 1 mL of either specific or universal irreversible caspase
inhibitor (5 mM stock in DMSO). Solutions were gently mixed
and left at 20uC for 5 min. Thereafter, 50 mLo f2 6 reaction
buffer supplemented with 10 mM dithiothreitol (1 M stock
solution) was added to each tube. Tubes designated to provide
background absorption received 26 reaction buffer without
substrate and the remaining tubes received 26 reaction buffer
containing paranitroanilin (pNA)-caspase substrate premixed at
a 200 mM concentration. Tubes were mixed by gentle vortexing
and incubated at 37uC for 2 h. Thereafter, 120 mL of dilution
buffer was added to each tube and aliquots of 200 ml were read at
405 nm in a microplate reader (Bio-Tek Instruments). Substrate-
specific caspase activity was defined the value of total pNA
conversion obtained from samples without caspase inhibitor
subtracted from values obtained from samples containing caspase
inhibitor.
The pNA-substrates considered specific for individual caspases
(obtained from BioVision or AnaSpec) are listed in Fig. 3. Specific
caspase inhibitors used were caspase-1 inhibitor II (AnaSpec),
caspase-2 inhibitor I (Calbiochem) and Z-VDVAD-FMK (BioVi-
sion), caspase-3 inhibitor I and II, caspase-3/7 inhibitor II,
caspase-4 inhibitor I, caspase-5 inhibitor I, caspase-6 inhibitor I,
caspase-8 inhibitor II, caspase-9 inhibitor I and III (all Calbio-
chem), and caspase-10 inhibitor AEVD-FMK (BioVision). The
universal caspase inhibitors used were caspase inhibitors III and
VI (Calbiochem).
For nuclear DNA fragmentation assays, NT2/D1 cells were
grown to 90% confluence in 25 cm
2 flasks (,6610
6 cells/flask).
Cells were then either harvested directly (control, time 0 min) or
exposed to 46–49 mM curcuminoids in DMEM with 5% FCS in
a total volume of 5 mL for 6, 12, or 18 hr, or cells were exposed to
5 mM camptothecin (BioVision) in the same medium for 6 hr.
Cells were trypsinized and processed with the Quick Apoptotic
Ladder Detection Kit (BioVision) according to the manufacturer’s
instructions except that the recommended volumes were doubled
to account for the higher cell counts. Ethidium bromide stained
gels were UV-transilluminated and photographed.
SA-b-galactosidase Staining
NT2/D1 cells were grown in 25 cm
2 flasks with standard
medium to about 70% confluence. Thereafter, cultures were
incubated in media containing 6 mM of SOLID- or DMSO-
solubilized curcuminoids that were changed every 24 h. Cultures
were stained for SA-b-galactosidase after 4 and 12 days in culture
essentially as described elsewhere [20,92]. Briefly, cells were
washed twice with 5 mL PBS (pH 7.4) and then fixed with 5 mL
0.5% glutaraldehyde in PBS (pH 7.4). Thereafter, cells were
washed 6 times with 5 mL PBS (pH 6). Finally, 40 mL of X-gal (5-
Bromo-4chloro-3-indolyl-b-D-galactoside, 50 mg/mL in N,N-
dimethylformamide) was added to 4 mL of PBS (pH 6) containing
5 mM potassium ferricyanide and 5 mM potassium ferrocyanide.
Cells were incubated in that solution for 6 h at 37uC without CO2.
Control cultures without curcuminoids were similarly processed.
Cells were viewed and photographed under phase contrast with
a Nikon Eclipse TE300 inverted microscope.
Cellular Curcuminoid Binding and Media Concentrations
NT2/D1 cells were grown in 25 cm
2 flasks to a density of about
90% confluence in standard medium. To establish a time course
for cellular binding of curcuminoids, cells were incubated for 5 h
with 5.6 mL of medium containing serum-solubilized curcumi-
noids (SOLID+DMSO, 1:1) diluted with standard medium to
achieve a final 27 mM concentration. At each indicated time point,
aliquots of 0.4 mL were taken from the media for butanol
extraction. The remaining media were aspirated and the cells were
washed three times with 5 mL of 0.9% NaCl. The cells were then
scraped into 1 mL of 0.9% NaCl and centrifuged at 2,0006g for
1 min. The pellet was resuspended in 1 mL of 0.6% NaCl and
aliquots of 10 ml were taken for protein determination. The cell
suspension was again centrifuged and the final pellet was
suspended in 0.4 mL of 0.6% NaCl and extracted with 0.8 mL
butanol. Cells and media were similarly processed to determine
changes in curcuminoid levels over a 24 h period except that the
incubation medium contained a starting concentration of 47 mM
curcuminoids (SOLID+DMSO, 1:1).
For curcuminoid dose curves to determine binding dissociation
constants with variable serum concentration, media were prepared
with increasing amounts (20 mL-6 mL) of curcuminoid-solubilized
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0.4 mL was removed for butanol extraction. Cells were then
incubated with the remaining 5.6 mL of media for 1 hr. For
curcuminoid dose curves at constant serum concentrations,
increasing amounts of serum-solubilized curcuminoids were mixed
with regular serum for constant total serum concentration of 5%,
50%, or 100% and diluted with DMEM in a total volume of
6 mL. Media for dose curves to determine cellular binding with
a constant amount of serum-solubilized curcuminoids (5%) and
increasing amounts of regular serum were similarly prepared with
DMEM. Cells and media were then collected and processed as
described above.
To determine the rate of dissociation of cellular-bound
curcuminoids, cells were first incubated with complete medium
containing 47 mM curcuminoids (SOLID+DMSO, 1:1) for 1 h.
The cells were then washed 36 with 5 mL of PBS and further
incubated with 2 mL of DMEM medium with or without 5% FCS
for another 2 h. At the indicated time points, the entire media
volumes were divided into five fractions of 0.4 mL and each
extracted with 0.8 mL butanol. The media fractions were
evaporated under vacuum and combined in 0.2 mL of FPLC
loading buffer for reversed phase chromatography. Cells were
harvested and processed as described above.
When the dissociation of cellular-bound curcuminoids was
examined under cell-free conditions, cells were first washed 26
with 5 mL of PBS and then briefly with 5 mL of hypotonic
10 mM hepes (pH 7). Cells were then incubated with 2 mL of
10 mM hepes, pH 7. This resulted in the rupture and detachment
of cells. At the indicated time points, the suspension of cell
fragments was collected and centrifuged at 18,0006g for 10 min.
The supernatants and pellets were processed as described above.
Detection of Metabolic Products
Metabolic products of curcuminoids were detected in in-
cubation media at 310 nm wavelength during reversed phase
chromatography. Metabolic products were quantitated by in-
cubating NT2/D1 cells (90% confluence in 25 cm
2 flasks) for 5 h
in 8 ml of media containing either 47 mM curcuminoids
(SOLID+DMSO, 1:1) in 5% FCS, 24 mM curcuminoids in
2.5% FCS, or 24 mM curcuminoids in 5% serum. Aliquots of
0.4 ml of media were removed at indicated time points, extracted
with 0.8 mL of butanol and processed as described. After reversed
phase chromatography, the areas under the peaks were adjusted
for media volume and plotted against time. At the end of the
incubation period, cells were harvested and processed as described
for curcuminoid binding.
For mass spectrometry of the CUR metabolic product, a 25 cm
2
flask with NT2/D1 cells at 90% confluence was incubated for 4 h
with 4 mL of DMEM medium containing 50 mM analytical grade
curcumin in 5% FCS. Ten aliquots of 0.4 mL were extracted with
0.8 mL of butanol and dried under vacuum. The dried residues
were each solubilized in 0.2 mL FPLC loading buffer and
separated by reversed phase chromatography. Absorption peaks
at 310 nm wavelength that corresponded to the CUR metabolic
product were collected and dried. The peak fractions were
sequentially dissolved in a total volume of 0.2 mL FPLC loading
buffer and again separated by chromatography. The metabolic
fraction of curcumin was this time collected as a single fraction.
Peaks containing CUR, Octahydrocurcumin, and tetrahydrocur-
cumin were similarly separated, collected and used as standards
for comparison. The collected fractions were again dried and
resolubilized in 0.1 mL of 50% acetonitrile. Aliquots were further
diluted with the same solution at a ratio of 1:5 and analyzed in
Thermo TSQ Quantum Access Triple Quadrupole and LTQ Ion
Trap mass spectrometers (Thermo-Fisher) at a flow rate of 5 mL/
min in negative ion mode.
To compare metabolic products generated by different cell
lines, NT2/D1, HeLa, and CCF-STTG1 cells (90% confluence in
25 cm
2 flasks) were incubated in 4 ml of media containing 47 mM
curcuminoids (SOLID+DMSO, 1:1). After 24 h, 0.4 ml aliquots
of media were butanol extracted and analyzed by reversed phase
chromatography at wavelengths of 280 nm and 310 nm. Octa-
and hexahydrocurcuminoids were identified by co-elution with
commercial standards and mass spectrometry.
Cell Fractionation
NT2/D1 cells were grown to 90% confluence in two 175 cm
2
flasks (,4610
7 cells) and incubated with 5% curcuminoid-
saturated serum (47 mM; SOLID+DMSO, 1:1) for 1 hr. Cells
were first rinsed 36 with 25 mL and then scraped into 10 mL
0.9% NaCl, combined, and centrifuged at 5,0006g. The cell pellet
was suspended in 2 mL PBS (pH 6.8), transferred to a microcen-
trifuge tube, and recentrifuged. The resulting pellet was rapidly
washed with 1 mL of 50 mM Tris, pH 6.8 and recentrifuged. The
final pellet was suspended in a total volume of 1.6 mL of 10 mM
Tris, pH 6.8 and divided into four equal parts. One part
representing the total cell content of curcuminoids, was directly
extracted with butanol. The remaining three parts (0.4 mL each)
were disrupted by three different procedures. One part was
homogenized in a 1 mL glass homogenizer (Wheaton) with a tight
pestle (20 strokes). To another part, 0.1 g of glass beads (Sigma,
425–600 mm) was added. This was followed by 3 freeze-thaw
cycles with vortexing during the thaw-phase. A third part was
placed in ice water and sonicated 36 at full power (Ultrasonic
Systems Inc., model 250) for 5 seconds each. Thereafter, 0.4 mL
of 500 mM sucrose, 50 mM Tris, pH 6.8, and 2.5 mM MgCl2
was added to each part. The samples were then sequentially
centrifuged at 1,0006g, 15,0006g, and 100,0006g (Fig. 6A). The
pellets after the first two centrifugations were washed once in 1 mL
of PBS (pH 6.8) and recentrifuged. The resulting pellets were
resuspended in 0.4 mL PBS (pH 6.8) and extracted with 0.8 mL
of butanol. After the final 100,0006g centrifugation, the entire
supernatants (0.6–0.7 mL) were extracted twice with 0.6 mL of
butanol and the extracts combined. The final pellet was directly
resuspended in 0.4 mL of 0.6% NaCl and extracted with 0.8 mL
of butanol. Before each extraction and after each step of the
procedure, aliquots of 3610 mL were withdrawn for protein
determination (BCA Protein Assay, Thermo Scientific) with
a mixture of RNase, Lysozyme and BSA (equal parts by weight)
as a reference standard. All butanol extracts were evaporated
under vacuum and the dry residues solubilized in 0.2 mL loading
buffer for reversed phase chromatography.
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